BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29156845)

  • 1. Metastatic to negative lymph node ratio demonstrates significant prognostic value in patients with esophageal squamous cell carcinoma after esophagectomy.
    Duan XF; Tang P; Shang XB; Jiang HJ; Yu ZT
    Oncotarget; 2017 Oct; 8(49):86908-86916. PubMed ID: 29156845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy.
    Zhang H; Liang H; Gao Y; Shang X; Gong L; Ma Z; Sun K; Tang P; Yu Z
    Sci Rep; 2016 Dec; 6():38804. PubMed ID: 27941828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?
    Tan Z; Ma G; Yang H; Zhang L; Rong T; Lin P
    J Thorac Oncol; 2014 Aug; 9(8):1214-21. PubMed ID: 25157776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes.
    Wu SG; Sun JY; Yang LC; Zhou J; Li FY; Li Q; Lin HX; Lin Q; He ZY
    Oncotarget; 2015 Nov; 6(34):36911-22. PubMed ID: 26426993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Lymph Node Ratio on Survival Outcome in Esophageal Squamous Cell Carcinoma After Minimally Invasive Esophagectomy.
    Kitamura Y; Oshikiri T; Takiguchi G; Urakawa N; Hasegawa H; Yamamoto M; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Nakamura T; Suzuki S; Kakeji Y
    Ann Surg Oncol; 2021 Aug; 28(8):4519-4528. PubMed ID: 33393049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between metastatic lymph node and prognosis of esophageal cancer patients treated with following radical esophagectomy].
    Deng WY; Wei C; Li N; Zhang YP; Shen W; Zhang C; Luo SX
    Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(47):3829-3832. PubMed ID: 28057100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.
    Wei C; Deng WY; Li N; Shen W; Zhang C; Liu JY; Luo SX
    Dig Dis Sci; 2015 Sep; 60(9):2771-6. PubMed ID: 25939544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio.
    Li Y; Zhao W; Ni J; Zou L; Yang X; Yu W; Fu X; Zhao K; Zhang Y; Chen H; Xiang J; Xie C; Zhu Z
    Ann Surg Oncol; 2019 Aug; 26(8):2367-2374. PubMed ID: 31187360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma.
    Shao Y; Geng Y; Gu W; Ning Z; Huang J; Pei H; Jiang J
    J Thorac Oncol; 2016 Oct; 11(10):1774-84. PubMed ID: 27393473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of lymph node ratio in esophageal cancer.
    Wang N; Jia Y; Wang J; Wang X; Bao C; Song Q; Tan B; Cheng Y
    Tumour Biol; 2015 Apr; 36(4):2335-41. PubMed ID: 25412956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.
    Chen P; Wang L; Yang X; Feng J
    Biomol Biomed; 2024 Jan; 24(1):159-169. PubMed ID: 37597214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Lymph Node Ratio in Locally Advanced Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Kano K; Yamada T; Komori K; Watanabe H; Takahashi K; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2021 Dec; 28(13):8464-8472. PubMed ID: 34114182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of different lymph node staging methods in esophageal squamous cell carcinoma after esophagectomy.
    Wu SG; Li FY; Zhou J; Lin Q; Sun JY; Lin HX; Guan XX; He ZY
    Ann Thorac Surg; 2015 Jan; 99(1):284-90. PubMed ID: 25440270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Significance of Lymph Node Ratio and Log Odds Ratio in Laryngeal Squamous Cell Carcinoma.
    Zhang X; Yu F; Zhao Z; Mai J; Zhou Y; Tan G; Liu X
    OTO Open; 2018; 2(3):2473974X18792008. PubMed ID: 31535064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery].
    Zheng Y; Chen Q; Liang Z; Jia M; Cao X
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):41-6. PubMed ID: 25877318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.
    Zhang BY; Yuan J; Cui ZS; Li ZW; Li XH; Lu YY
    Am J Surg; 2014 Apr; 207(4):555-65. PubMed ID: 24124661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer.
    Attaallah W; Uprak K; Gunal O; Yegen C
    Indian J Surg Oncol; 2016 Mar; 7(1):67-72. PubMed ID: 27065685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.